Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
300 participants
OBSERVATIONAL
2025-08-14
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fatigue, Sleep and Quality of Life in Parkinson's Patients
NCT05687799
The Quality of Life in Individuals With Parkinson's Disease
NCT05906693
Turkish Validation of the Parkinson Disease Cognitive Functional Rating Scale
NCT07253376
Bone Mineral Density Changes Among Clinical Subtypes of Parkinson's Disease
NCT03806517
A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
NCT00387075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Parkinson's Disease Patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist
* Both male and postmenopausal female patients
* Patients able to provide informed consent
* Clinically stable enough to undergo blood and saliva sampling, as well as neurological assessment
Exclusion Criteria
* Patients with secondary or atypical parkinsonism (e.g., drug-induced, vascular, atypical parkinsonian syndromes)
* Known endocrine disorders affecting prolactin levels (e.g., prolactinoma, pituitary adenoma, hypothyroidism)
* Use of medications known to alter prolactin secretion (e.g., antipsychotics, dopamine antagonists, estrogen therapy)
* History of other neurodegenerative diseases (e.g., Alzheimer's, Huntington's)
* Presence of active infection, chronic inflammatory disease, or malignancy
* Severe renal, hepatic, or cardiac failure
* Inability to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Çanakkale Onsekiz Mart University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hüseyin Avni Eroğlu
Assoc. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Çanakkale Onsekiz Mart University
Çanakkale, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NOT YET
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
COMU-FNN-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.